[{"AccountsPayableCurrent_0_Q1_USD":15850000.0,"DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_1_Q1_USD":100000.0,"DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_1_Q1_USD":3708000.0,"DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_0_Q1_USD":513000.0,"CostsIncurredAssetRetirementObligationIncurred_1_Q1_USD":166000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-23639000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":8847000.0,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":6100000.0,"LongTermInvestments_0_Q1_USD":35120000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1535000.0,"AssetRetirementObligationLiabilitiesSettled_1_Q1_USD":292000.0,"AssetRetirementObligationCurrent_0_Q1_USD":432000.0,"DisposalGroupIncludingDiscontinuedOperationOperatingExpense_1_Q1_USD":292000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":310078000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":8847000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":102421000.0,"ShortTermInvestments_0_Q1_USD":263875000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":54589000.0,"DebtInstrumentInterestRateDuringPeriod_1_Q1_pure":0.0781,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-24700000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":105684000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":6791000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-1368000.0,"TaxesPayableCurrent_0_Q1_USD":1737000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":5900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1_Q1_USD":13046000.0,"InvestmentIncomeInterest_1_Q1_USD":1589000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":3455000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-22000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":28747000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-1368000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":20.97,"DepreciationDepletionAndAmortization_1_Q1_USD":4821000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":42032000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1_Q1_USD":-4489000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":23162000.0,"SupplementalUnemploymentBenefitsSeveranceBenefits_0_Q1_USD":81000.0,"SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount_0_Q1_USD":6979000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1_Q1_shares":0.0,"SeveranceCosts1_1_Q1_USD":0.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":174000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":104745000.0,"RestrictedStockExpense_1_Q1_USD":2402000.0,"RepaymentsOfDebt_1_Q1_USD":0.0,"ProceedsFromSaleOfShortTermInvestments_1_Q1_USD":50768000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":72610000.0,"PaymentsForPostemploymentBenefits_1_Q1_USD":0.0,"PaymentForContingentConsiderationLiabilityOperatingActivities_1_Q1_USD":264000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":4736000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0755,"OperatingLeaseRightOfUseAsset_0_Q1_USD":37613000.0,"OperatingLeasePayments_1_Q1_USD":2759000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":40189000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":7757000.0,"LeaseCost_1_Q1_USD":2012000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":63319000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":32830000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":6155000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":6013000.0,"IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements_1_Q1_shares":585000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":5875000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":6116000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":19162000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"OperatingLeaseCost_1_Q1_USD":1564000.0,"OperatingLeaseLiability_0_Q1_USD":44157000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3968000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":6330000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":4000000.0,"SharePrice_0_Q1_USD":33.53,"Goodwill_0_Q1_USD":99547000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-391239000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":108105000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":14476000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":6724000.0,"NetIncomeLoss_1_Q1_USD":8159000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":6208000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-28566000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-1281000.0,"LiabilitiesCurrent_0_Q1_USD":80313000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":821379000.0,"Liabilities_0_Q1_USD":447342000.0,"InventoryNet_0_Q1_USD":59666000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":3674000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-8542000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2868000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":398000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":8557000.0,"AccountsReceivableNetCurrent_0_Q1_USD":38988000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-1046000.0,"AdditionalPaidInCapital_0_Q1_USD":766280000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":5385000.0,"Assets_0_Q1_USD":821379000.0,"AssetsCurrent_0_Q1_USD":431594000.0,"StockholdersEquity_0_Q1_USD":374037000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":54589000.0,"CommonStockSharesOutstanding_0_Q1_shares":42116545.0,"CommonStockValue_0_Q1_USD":42000.0,"CostOfRevenue_1_Q1_USD":29732000.0,"CostsAndExpenses_1_Q1_USD":88590000.0,"Depreciation_1_Q1_USD":2900000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":0.19,"CommonStockSharesIssued_0_Q1_shares":42116545.0,"NonoperatingIncomeExpense_1_Q1_USD":-8537000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":44717000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":10000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-3874000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-4104000.0,"InterestReceivable_0_Q1_USD":1600000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":102421000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":110090000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":3594000.0,"GainLossOnInvestments_1_Q1_USD":-3971000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":186299000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-1173000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1370000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":1967000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":78194000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":42785000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":3455000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1_Q1_pure":0.85,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockSharesAuthorized_0_Q1_shares":250000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":7669000.0,"InterestExpense_1_Q1_USD":6022000.0,"InterestPaidNet_1_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":17094000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockValue_0_Q1_USD":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":15819000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":44780000.0,"ShareBasedCompensation_1_Q1_USD":8847000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"VariableLeaseCost_1_Q1_USD":448000.0,"Ticker":"PCRX","CIK":"1396814","name":"PACIRA BIOSCIENCES, INC.","OfficialName":"Pacira BioSciences Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3316489486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]